Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 2, 2015, Pages 470-480

  Zhang, Hui ^a   Chen, Yiqian ^a   Wadham, Carol ^a,b   McCaughan, Geoffrey W ^a   Keane, Fiona M ^a   Gorrell, Mark D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Dipeptidyl peptidase; Focal adhesion; Localization; Migration

Indexed keywords

BETA1 INTEGRIN; DIPEPTIDYL PEPTIDASE; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE; PAXILLIN; PHORBOL 13 ACETATE 12 MYRISTATE; TALIN; COLLAGEN; DPP9 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR DERIVATIVE; FIBRONECTIN;

ARTICLE; CELL ADHESION; CELL ADHESION ASSAY; CELL MIGRATION; CELL MOTION; CELLULAR DISTRIBUTION; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; MICROTUBULE; MITOCHONDRION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEADY STATE; STIMULATION; TUMOR GROWTH; ANTAGONISTS AND INHIBITORS; CELL FRACTIONATION; CELL MEMBRANE; DOWN REGULATION; DRUG EFFECTS; FOCAL ADHESION; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ANTIGENS, CD29; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; COLLAGEN; DIPEPTIDYL-PEPTIDASES AND TRIPEPTIDYL-PEPTIDASES; DOWN-REGULATION; EGF FAMILY OF PROTEINS; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; HUMANS; MICROTUBULES; PAXILLIN; PHOSPHORYLATION; SUBCELLULAR FRACTIONS; TALIN; TETRADECANOYLPHORBOL ACETATE;

EID: 84919915612     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.11.029     Document Type: Article

References (50)

1. Keane F.M., Chowdhury S., Yao T.-W., Nadvi N.A., Gall M.G., Chen Y., Osborne B., Vieira de Ribeiro A.J., Church W.B., McCaughan G.W., Gorrell M.D., Yu D.M.T. Targeting Dipeptidyl Peptidase-4 (DPP-4) and Fibroblast Activation Protein (FAP) for diabetes and cancer therapy. Proteinases as Drug Targets 2012, 119-145. Royal Society of Chemistry, Cambridge, UK. B. Dunn (Ed.).
2. Yu D.M.T., Yao T.-W., Chowdhury S., Nadvi N.A., Osborne B., Church W.B., McCaughan G.W., Gorrell M.D. The dipeptidyl peptidase IV family in cancer and cell biology. FEBS J. 2010, 277:1126-1144.
3. Chowdhury S., Chen Y., Yao T.-W., Ajami K., Wang X.M., Popov Y., Schuppan D., Bertolino P., McCaughan G.W., Yu D.M., Gorrell M.D. Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. World J. Gastroenterol. 2013, 19:2883-2893.
4. Kirby M.S., Yu D.M.T., O'Connor S.P., Gorrell M.D. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. Clin. Sci. 2010, 118:31-41.
5. Hamson E.J., Keane F.M., Tholen S., Schilling O., Gorrell M.D. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin. Appl. 2014, 8:454-463.
6. Zhang H., Chen Y., Keane F.M., Gorrell M.D. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9. Mol. Cancer Res. 2013, 11:1487-1496.
7. Harstad E.B., Rosenblum J.S., Gorrell M.D., Achanzar W.E., Minimo L., Wu J., Rosini-Marthaler L., Gullo R., Ordway N.D., Kirby M.S., Chadwick K.D., Cosma G.N., Moyer C.F. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues. Regul. Pept. 2013, 186:26-35.
8. Yu D.M.T., Ajami K., Gall M.G., Park J., Lee C.S., Evans K.A., McLaughlin E.A., Pitman M.R., Abbott C.A., McCaughan G.W., Gorrell M.D. The in vivo expression of dipeptidyl peptidases 8 and 9. J. Histochem. Cytochem. 2009, 57:1025-1040.
9. Yao T.-W., Kim W.-S., Yu D.M., Sharbeen G., McCaughan G.W., Choi K.-Y., Xia P., Gorrell M.D. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling. Mol. Cancer Res. 2011, 9:948-959.
10. Schade J., Stephan M., Schmiedl A., Wagner L., Niestroj A.J., Demuth H.U., Frerker N., Klemann C., Raber K.A., Pabst R., von Horsten S. Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats. J. Histochem. Cytochem. 2008, 56:147-155.
11. Yazbeck R., Sulda M.L., Howarth G.S., Bleich A., Raber K., von Hörsten S., Holst J.J., Abbott C.A. Dipeptidyl peptidase expression during experimental colitis in mice. Inflamm. Bowel Dis. 2010, 16:1340-1351.
12. Sulda M.L., Abbott C.A., Macardle P.J., Hall R.K., Kuss B.J. Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia. Cancer Biol. Ther. 2010, 10:180-189.
13. Abbott C.A., Yu D.M.T., Woollatt E., Sutherland G.R., McCaughan G.W., Gorrell M.D. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur. J. Biochem. 2000, 267:6140-6150.
14. Ajami K., Abbott C.A., McCaughan G.W., Gorrell M.D. Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. BBA - Gene Structure Expression 2004, 1679:18-28.
15. Justa-Schuch D., Möller U., Geiss-Friedlander R. The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus. Cell. Mol. Life Sci. 2014, 1-16.
16. Yu D.M.T., Wang X.M., McCaughan G.W., Gorrell M.D. Extra-enzymatic functions of the dipeptidyl peptidase (DP) IV related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J. 2006, 273:2447-2461.
17. Lu C., Tilan J., Everhart L., Czarnecka M., Soldin S., Mendu D., Jeha D., Hanafy J., Lee C., Sun J., Izycka-Swieszczew E., Toretsky J., Kitlinska J. Dipeptidyl peptidases as survival factors in Ewing's sarcoma family of tumors: implications for tumor biology and therapy. J. Biol. Chem. 2011, 286:27494-27505.
18. Pilla E., Möller U., Sauer G., Mattiroli F., Melchior F., Geiss-Friedlander R. A novel SUMO1-specific interacting motif in dipeptidyl peptidase 9 (DPP9) that is important for enzymatic regulation. J. Biol. Chem. 2012, 287:44320-44329.
19. Pilla E., Kilisch M., Lenz C., Urlaub H., Geiss-Friedlander R. The SUMO1-E67 interacting-loop peptide is an allosteric inhibitor of dipeptidyl peptidases 8 and 9. J. Biol. Chem. 2013, 288:32787-32796.
20. Spagnuolo P.A., Hurren R., Gronda M., Maclean N., Datti A., Basheer A., Lin F.H., Wang X., Wrana J., Schimmer A.D. Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity. Leukemia 2013, 27:1236-1244.
21. Walsh M.P., Duncan B., Larabee S., Krauss A., Davis J.P., Cui Y., Kim S.Y., Guimond M., Bachovchin W., Fry T.J. Val-BoroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors. PLoS ONE 2013, 8:e58860.
22. Lankas G., Leiting B., Roy R., Eiermann G., Beconi M., Biftu T., Chan C., Edmondson S., Feeney W., He H., Ippolito D., Kim D., Lyons K., Ok H., Patel R., Petrov A., Pryor K., Qian X., Reigle L., Woods A., Wu J., Zaller D., Zhang X., Zhu L., Weber A., Thornberry N. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes-potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes 2005, 54:2988-2994.
23. Puche J.E., Saiman Y., Friedman S.L. Hepatic stellate cells and liver fibrosis. Compr. Physiol. 2013, 3:1473-1492.
24. Matheeussen V., Waumans Y., Martinet W., Van Goethem S., Van der Veken P., Scharpe S., Augustyns K., De Meyer G.R., De Meester I. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis. Basic Res. Cardiol. 2013, 108:350.
25. Gall M.G., Chen Y., Ribeiro A.J.V.d., Zhang H., Bailey C.G., Spielman D., Yu D.M., Gorrell M.D. Targeted inactivation of dipeptidyl peptidase 9 enzyme activity causes mouse neonate lethality. PLoS ONE 2013, 8:e0078378.
26. Friedl P., Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat. Rev. Mol. Cell Biol. 2009, 10:445-457.
27. Theveneau E., Mayor R. Collective cell migration of epithelial and mesenchymal cells. Cell. Mol. Life Sci. 2013, 70:3481-3492.
28. Wozniak M.A., Modzelewska K., Kwong L., Keely P.J. Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta 2004, 1692:103-119.
29. Serrels B., Serrels A., Brunton V.G., Holt M., McLean G.W., Gray C.H., Jones G.E., Frame M.C. Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex. Nat. Cell Biol. 2007, 9:1046-1056.
30. Vicente-Manzanares M., Horwitz A.R. Adhesion dynamics at a glance. J. Cell Sci. 2011, 124:3923-3927.
31. Sastry S.K., Burridge K. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp. Cell Res. 2000, 261:25-36.
32. Siesser P.M., Hanks S.K. The signaling and biological implications of FAK overexpression in cancer. Clin. Cancer Res. 2006, 12:3233-3237.
33. Gabarra-Niecko V., Schaller M.D., Dunty J.M. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev. 2003, 22:359-374.
34. Turner C.E. Paxillin and focal adhesion signalling. Nat. Cell Biol. 2000, 2:E231-E236.
35. Kaji K., Yoshiji H., Ikenaka Y., Noguchi R., Aihara Y., Douhara A., Moriya K., Kawaratani H., Shirai Y., Yoshii J., Yanase K., Kitade M., Namisaki T., Fukui H. Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J. Gastroenterol. 2013, 1-11.
36. Kwak T.K., Lee M.S., Ryu J., Choi Y.J., Kang M., Jeong D., Lee J.W. Cell adhesion-dependent serine 85 phosphorylation of paxillin modulates focal adhesion formation and haptotactic migration via association with the C-terminal tail domain of talin. J. Biol. Chem. 2012, 287:27499-27509.
37. Wu J.J., Tang H.K., Yeh T.K., Chen C.M., Shy H.S., Chu Y.R., Chien C.H., Tsai T.Y., Huang Y.C., Huang Y.L., Huang C.H., Tseng H.Y., Jiaang W.T., Chao Y.S., Chen X. Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. Biochem. Pharmacol. 2009, 78:203-210.
38. Gamble J.R., Matthias L.J., Meyer G., Kaur P., Russ G., Faull R., Berndt M.C., Vadas M.A. Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell Biol. 1993, 121:931-943.
39. Wang X.M., Yu D.M.T., McCaughan G.W., Gorrell M.D. Fibroblast activation protein increases apoptosis, cell adhesion and migration by the LX-2 human stellate cell line. Hepatology 2005, 42:935-945.
40. Zink S., Grosse L., Freikamp A., Banfer S., Muksch F., Jacob R. Tubulin detyrosination promotes monolayer formation and apical trafficking in epithelial cells. J. Cell Sci. 2012, 125:5998-6008.
41. Osborne B., Yao T.-W., Wang X.M., Chen Y., Kotan L.D., Nadvi N.A., Herdem M., McCaughan G.W., Allen J., Yu D.M., Topaloglu A.K., Gorrell M.D. A rare variant in human fibroblast activation protein associated with ER stress, loss of function and loss of cell surface localisation. BBA Proteins and Proteomics 2014, 1844:1248-1259.
42. Humphries M.J. Cell adhesion assays. Methods Mol. Biol. 2009, 522:203-210.
43. Hiroyama M., Exton J.H. Studies of the roles of ADP-ribosylation factors and phospholipase D in phorbol ester-induced membrane ruffling. J. Cell. Physiol. 2005, 202:608-622.
44. Kumamoto R., Uto H., Oda K., Ibusuki R., Tanoue S., Arima S., Mawatari S., Kumagai K., Numata M., Tamai T., Moriuchi A., Fujita H., Oketani M., Ido A., Tsubouchi H. Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat. Eur. J. Med. Res. 2013, 18:54.
45. Vicente-Manzanares M., Horwitz A.R. Cell migration: an overview. Methods Mol. Biol. 2011, 769:1-24.
46. Rainczuk A., Rao J.R., Gathercole J.L., Fairweather N.J., Chu S., Masadah R., Jobling T.W., Deb-Choudhury S., Dyer J., Stephens A.N. Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours. Int. J. Cancer 2014, 134:530-541.
47. Wilson C.H., Indarto D., Doucet A., Pogson L.D., Pitman M.R., Menz R.I., McNicholas K., Overall C.M., Abbott C.A. Identifying natural substrates for dipeptidyl peptidase 8 (DP8) and DP9 using terminal amine isotopic labelling of substrates, TAILS, reveals in vivo roles in cellular homeostasis and energy metabolism. J. Biol. Chem. 2013, 288:13936-13949.
48. Chen D., Kennedy A., Wang J.-Y., Zeng W., Zhao Q., Pearl M., Zhang M., Suo Z., Nesland J.M., Qiao Y., Ng A.-K., Hirashima N., Yamane T., Mori Y., Mitsumata M., Ghersi G., Chen W.-T. Activation of EDTA-resistant gelatinases in malignant human tumors. Cancer Res. 2006, 66:9977-9985.
49. Bank U., Heimburg A., Wohlfarth A., Koch G., Nordhoff K., Julius H., Helmuth M., Breyer D., Reinhold D., Tager M., Ansorge S. Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects. Biol. Chem. 2011, 392:169-187.
50. Ohishi W., Cologne J.B., Fujiwara S., Suzuki G., Hayashi T., Niwa Y., Akahoshi M., Ueda K., Tsuge M., Chayama K. Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study. Int. J. Cancer 2014, 134:154-163.